Skip to main content
PETS logo

PETS

Petmed Express Inc
$1.96 +0.00 (+0.00%) At close · Jul 10
Market Cap
$41.88M
Shares
21,365,782

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.96 Open$1.95 Day$1.95–1.99 52W$1.57–4.10 Avg vol 30d1.2M Short int1.6M · 7.6% float · 1.0d Short vol33% Last earningsJun 2, 2026 DataJan 2020–Jul 2026 Filing10-K · Jun 2
Up next
Next earnings call
Sep 21, 2026 Est · unconfirmed · in 10 wks
FQ2-27 quarter ends
~Sep 30, 2026 Est
filed Jun 2, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Equibles Rating blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 15 · calm Equity put/call 0.55
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −21%
      below
      Price vs 50-day avg −4%
      below
      RSI (14) 53
      neutral
      MACD trend Positive
      52-week position 15%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return +14%
      trailing
      6-month return −42%
      trailing
      YTD return −39%
      this year
      Relative strength −51%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $2 › 200d $2 — 200d above 50d
      Institutional flow Distributing
      2 of 50 funds reported for Jun 30 · net -78 sh shares
      Insider flow Accumulating
      Net +$43.7K over 90 days · 0% sells
      Short interest Rising
      7.57% of float · ▲ +164.2% MoM · 1.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      50 holders — near 3-yr low, contrarian setup
      Squeeze score 71
      high risk · 0–100
      Fundamentals
      Strong
      Revenue growth +24%
      Y/Y
      Gross margin 68%
      contracting
      EPS growth −813%
      Y/Y
      Free cash flow $-33.0M
      Buyback $28.7M
      remaining
      Balance sheet $21.4M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 98%
      annualized · 1-yr
      Max drawdown −60%
      past year
      ATR 5.8%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 5 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −21% Bearish
      Price vs 50-day avg
      −4% Neutral
      RSI (14)
      53 Neutral
      MACD trend
      Positive Bullish
      52-week position
      15% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $2 › 200d $2 — 200d above 50d
      Institutional flow Distributing
      2 of 50 funds reported for Jun 30 · net -78 sh shares
      Insider flow Accumulating
      Net +$43.7K over 90 days · 0% sells
      Short interest Rising
      7.57% of float · ▲ +164.2% MoM · 1.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      50 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      52-wk low $2 Now $2 · 15% 52-wk high $4
      vs 200-day avg -21% vs 50-day avg -4%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Adjusted EBITDA non-GAAP -$15.4M Full Year Fiscal 2026
      Adjusted EBITDA loss non-GAAP -$2.8M Q4 FY2026 call

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Pharmaceutical Retailers — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      PETS
      Petmed Express Inc
      this stock
      $41.88M -38.8% -21.1% 7.6%
      RTEZ
      REST EZ Inc.
      $1.93B +0.0% 0.0%
      WGRX
      Wellgistics Health, Inc.
      $385.81M -84.7% +0.0% 0.1%
      HITI
      High Tide Inc.
      $192.79M -16.6% 0.8%
      BHIC
      BioScience Health Innovations, Inc.
      $49.58M +8.6% +208.3% 144.8 0.0%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      50
      % held
      28.2%
      Reported
      2 of 50
      Top holder
      RENAISSANCE TECHNOLOGIES…
      Held Float
      View
      Held by Funds
      Fund positions
      45
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      1.6M
      Days to cover
      1.0d
      Change
      +1.0M sh
      View
      Short Volume
      Short vol %
      33%
      As of
      Jul 10, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      12.1K
      Value
      $22.3K
      As of
      Jun 12, 2026
      View
      Off-Exchange
      Off-exchange %
      67.2%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$43.7K
      Buyers / Sellers
      1 / 0
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $179.0M
      Net income (FY)
      $-57.3M
      EPS diluted
      $-2.74
      View
      Buybacks
      Authorized
      $110.0M
      Remaining
      $28.7M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 26, 2026
      This year
      7
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jun 2, 2026
      View
      Investor Relations
      Latest news
      PetMed Express, Inc. Confirms Rec…
      Published
      Jun 30, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      PETS -1.0% +14.0% -42.4% +2.1% -38.8%
      SPY +1.4% +4.1% +9.1% +1.1% +10.7%
      vs SPY -2.4% +9.9% -51.4% +1.0% -49.5%

      Capital returns

      Buyback program · as of Dec 31, 2023
      Authorized
      $110.00M
      Spent (derived)
      $81.30M
      Remaining
      $28.70M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1040130 CUSIP 716382106 13F (30d) 3 filings 3 filers Visit website Investor relations